Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Feb 29;395(10225):683-684.
doi: 10.1016/S0140-6736(20)30361-5. Epub 2020 Feb 12.

On the use of corticosteroids for 2019-nCoV pneumonia

Lianhan Shang  1 , Jianping Zhao  2 , Yi Hu  3 , Ronghui Du  4 , Bin Cao  5
Affiliations
Comment

On the use of corticosteroids for 2019-nCoV pneumonia

Lianhan Shang et al. Lancet. .
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

    1. Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020 doi: 10.1016/S0140-6736(20)30317-2. published online Feb 7. - DOI - PMC - PubMed
    1. WHO Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Jan 28, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-ac...
    1. Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006;3:e343. - PMC - PubMed
    1. Chen RC, Tang XP, Tan SY, et al. Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience. Chest. 2006;129:1441–1452. - PMC - PubMed
    1. Li H, Yang SG, Gu L, et al. Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia. Influenza Other Respir Viruses. 2017;11:345–354. - PMC - PubMed

Substances